Related Experiment Video
Updated: Jun 18, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Understanding time to peak effect of propofol as sole agent on bispectral index in children aged 2-12 years
Gil Gavel1,2, Gilbert Koch3, Axel Terrier4
1St. Anna Kinderspital, Wien, Austria.
Insights
Propofol
Area of Science:
- Pharmacology
- Pediatric Anesthesia
- Pharmacokinetics
Background:
- Previous propofol pharmacodynamic studies in children were potentially confounded by co-administered drugs.
- Age-dependent differences in propofol onset have been suggested but not definitively established.
- This study aimed to isolate the effects of age and weight on propofol's hypnotic onset.
Purpose of the Study:
- To characterize the influence of age and weight on the onset of propofol's hypnotic effects in children.
- To determine the time to peak propofol effect-site concentration without confounding medications.
- To compare propofol's onset in younger (2-6 years) versus older (8-12 years) children.
Main Methods:
- Prospective observational cohort study of 46 healthy children (2-12 years).
- Propofol administered via target-controlled infusion using the Paedfusor model.
- Bispectral Index (BIS) and infusion pump data recorded; nonlinear mixed-effects modeling used.
Main Results:
- Time to peak propofol effect-site concentration was significantly influenced by age and weight (p < .01).
- Older children (8-12 years) had a longer time to peak effect (99 secs) compared to younger children (2-6 years) (84 secs).
- Weight also affected time to peak effect, with heavier children (30-63 kg) showing longer onset times (99 secs) than lighter children (11-25 kg) (82 secs).
Conclusions:
- Both age and weight significantly influence the time to peak propofol effect in children.
- In the absence of opioids and benzodiazepines, propofol's onset is approximately 20% longer in older children (8-12 years) compared to younger children.
- These findings highlight the importance of individualized propofol dosing titration based on age and weight.
Background:
The pharmacodynamics of propofol in children have previously been described with the proprietary bispectral index (BIS) as an effect-site marker, and it has been suggested that the rate of onset of propofol might be age dependent, that is, a shorter time to peak effect in younger children. However, these analyses were potentially confounded by co-administered drugs, in particular opioids and benzodiazepines. Thus, the goal of this prospective study was to characterize the influence of age and weight on the onset of hypnotic effects from propofol, reflected by the time to peak of propofol effect-site concentration in the absence of additional drugs.
Methods:
A total of 46 healthy children aged 2-12 years presenting for elective surgery were included in our observational cohort study. Solely propofol was administered via a target-controlled infusion pump programmed with the Paedfusor pharmacokinetic model. The BIS and infusion pump data were recorded. The effect of an induction "bolus" was recorded having stopped the pump once a propofol plasma target concentration of 7 μg.mL-1 was achieved. A direct-response and an indirect-response model in the context of nonlinear mixed-effects modeling was used to characterize and compare BIS data in children aged 2-6 years and older children aged 8-12 years.
Results:
Time to peak of propofol effect-site concentration had a difference (p-value <.01) for age and weight, that is 84 [74, 96] (median [IQR] secs for children aged 2-6 years vs. 99 [91, 113] secs for children aged 8-12 years and 82 [71, 95] secs for weight 11-25 kg vs. 99 [91, 114] secs for weight 30-63 kg). The plasma effect-site equilibration rate constant for propofol had a heterogeneous distribution with a median of 2.36 (IQR: 2.05-2.93; range: 0.83-7.31) per minute but showed a weight-dependent effect in patients with weight below 45 kg.
Conclusions:
In children, the age and weight have an influence on time to peak effect of propofol. In the absence of opioids and benzodiazepines, time to peak effect was approximately 20% longer in children aged 8-12 years as compared to younger children. Such clinically relevant age and weight effects are an important consideration in the individualized titration of propofol dosing.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
07:27How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Depolarizing Blockers: Pharmocokinetics
Sedatives and Hypnotics Drugs: Barbiturates